AR248045A1 - Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia - Google Patents
Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferenciaInfo
- Publication number
- AR248045A1 AR248045A1 AR92322400A AR32240092A AR248045A1 AR 248045 A1 AR248045 A1 AR 248045A1 AR 92322400 A AR92322400 A AR 92322400A AR 32240092 A AR32240092 A AR 32240092A AR 248045 A1 AR248045 A1 AR 248045A1
- Authority
- AR
- Argentina
- Prior art keywords
- recombinant
- viruses
- avipox
- protein
- expression
- Prior art date
Links
- 241000700663 Avipoxvirus Species 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 3
- 108700026244 Open Reading Frames Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE9100507A BE1004877A3 (fr) | 1991-05-27 | 1991-05-27 | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR248045A1 true AR248045A1 (es) | 1995-05-31 |
Family
ID=3885526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR92322400A AR248045A1 (es) | 1991-05-27 | 1992-05-26 | Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0517292B1 (enExample) |
| JP (1) | JP3411307B2 (enExample) |
| KR (1) | KR100244601B1 (enExample) |
| CN (1) | CN1055501C (enExample) |
| AR (1) | AR248045A1 (enExample) |
| AT (1) | ATE189480T1 (enExample) |
| AU (1) | AU656185B2 (enExample) |
| BE (1) | BE1004877A3 (enExample) |
| BR (1) | BR9202024A (enExample) |
| CA (1) | CA2069594A1 (enExample) |
| DE (1) | DE69230627T2 (enExample) |
| DK (1) | DK0517292T3 (enExample) |
| ES (1) | ES2145000T3 (enExample) |
| HU (1) | HU215531B (enExample) |
| IE (1) | IE921686A1 (enExample) |
| IL (1) | IL101780A (enExample) |
| MX (1) | MX9202512A (enExample) |
| NZ (1) | NZ242620A (enExample) |
| PT (1) | PT517292E (enExample) |
| RU (1) | RU2130971C1 (enExample) |
| SG (1) | SG49876A1 (enExample) |
| TW (1) | TW288048B (enExample) |
| ZA (1) | ZA923321B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2110505A1 (en) * | 1991-07-26 | 1993-02-18 | Enzo Paoletti | Infectious bursal disease virus recombinant poxvirus vaccine |
| ATE286137T1 (de) * | 1992-01-13 | 2005-01-15 | Virogenetics Corp | Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus |
| FR2697534A1 (fr) * | 1992-11-02 | 1994-05-06 | Rhone Merieux | Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu. |
| US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
| AU6299594A (en) * | 1993-02-26 | 1994-09-14 | Nippon Zeon Co., Ltd. | Recombinant fowlpox virus s-fpv-043 and uses thereof |
| US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
| FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
| FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
| GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| US7041439B2 (en) * | 2001-04-17 | 2006-05-09 | Embrex, Inc. | Methods and apparatus for selectively processing eggs having identified characteristics |
| GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| GB2382578A (en) * | 2001-11-30 | 2003-06-04 | Isis Innovation | Fowlpox-based vaccine |
| EP1450854A2 (en) | 2001-11-30 | 2004-09-01 | Isis Innovation Limited | Vaccine |
| PL216760B1 (pl) * | 2002-05-16 | 2014-05-30 | Bavarian Nordic As | Rekombinowany modyfikowany wirus krowianki Ankara oraz sposób jego otrzymywania i zastosowania |
| EP1601333B1 (en) * | 2003-02-20 | 2013-01-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Novel insertion sites in pox vectors |
| GB2402391A (en) * | 2003-06-04 | 2004-12-08 | Oxxon Pharmaccines Ltd | Fowlpox recombinant genome |
| EP2785373B1 (en) | 2011-11-30 | 2019-11-20 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof |
| EP2845904A1 (en) | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
| EP3050572A1 (en) | 2015-01-29 | 2016-08-03 | Ceva Sante Animale | Recombinant MDV1 and the uses thereof |
| EP3263129A1 (en) | 2016-06-29 | 2018-01-03 | Ceva Sante Animale | Duck enteritis virus and the uses thereof |
| CN117357642A (zh) | 2016-12-14 | 2024-01-09 | 勃林格殷格翰动物保健美国公司 | 表达禽病原体的多种抗原的重组hvt载体及其用途 |
| CN113347992A (zh) | 2018-12-27 | 2021-09-03 | 法国诗华大药厂 | 重组病毒和其用途 |
| MA58717A1 (fr) | 2020-06-17 | 2023-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations |
| TWI812936B (zh) | 2021-04-01 | 2023-08-21 | 智勝科技股份有限公司 | 研磨墊及研磨方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
| FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
| US5310671A (en) * | 1988-06-24 | 1994-05-10 | British Technology Group Limited | Fowlpox virus non-essential regions |
| US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
| AU623476B2 (en) * | 1988-12-29 | 1992-05-14 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
| AU643216B2 (en) * | 1989-05-30 | 1993-11-11 | Commonwealth Scientific And Industrial Research Organisation | Production of IBDV VP2 in highly immunogenic form |
-
1991
- 1991-05-27 BE BE9100507A patent/BE1004877A3/fr active
-
1992
- 1992-03-19 SG SG9608014A patent/SG49876A1/en unknown
- 1992-05-05 IL IL10178092A patent/IL101780A/xx active IP Right Grant
- 1992-05-06 TW TW081103546A patent/TW288048B/zh active
- 1992-05-06 NZ NZ242620A patent/NZ242620A/xx unknown
- 1992-05-07 ZA ZA923321A patent/ZA923321B/xx unknown
- 1992-05-18 AU AU16323/92A patent/AU656185B2/en not_active Ceased
- 1992-05-19 PT PT92201406T patent/PT517292E/pt unknown
- 1992-05-19 ES ES92201406T patent/ES2145000T3/es not_active Expired - Lifetime
- 1992-05-19 DK DK92201406T patent/DK0517292T3/da active
- 1992-05-19 DE DE69230627T patent/DE69230627T2/de not_active Expired - Fee Related
- 1992-05-19 EP EP92201406A patent/EP0517292B1/fr not_active Expired - Lifetime
- 1992-05-19 AT AT92201406T patent/ATE189480T1/de not_active IP Right Cessation
- 1992-05-26 HU HU9201746A patent/HU215531B/hu not_active IP Right Cessation
- 1992-05-26 AR AR92322400A patent/AR248045A1/es active
- 1992-05-26 CA CA002069594A patent/CA2069594A1/fr not_active Abandoned
- 1992-05-27 MX MX9202512A patent/MX9202512A/es unknown
- 1992-05-27 BR BR929202024A patent/BR9202024A/pt not_active Application Discontinuation
- 1992-05-27 RU SU5052222A patent/RU2130971C1/ru active
- 1992-05-27 JP JP13533192A patent/JP3411307B2/ja not_active Expired - Fee Related
- 1992-05-27 CN CN92105030A patent/CN1055501C/zh not_active Expired - Fee Related
- 1992-05-27 KR KR1019920009005A patent/KR100244601B1/ko not_active Expired - Fee Related
- 1992-07-01 IE IE168692A patent/IE921686A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA923321B (en) | 1993-01-27 |
| EP0517292A1 (fr) | 1992-12-09 |
| HUT62331A (en) | 1993-04-28 |
| AU656185B2 (en) | 1995-01-27 |
| IL101780A (en) | 2000-12-06 |
| ATE189480T1 (de) | 2000-02-15 |
| RU2130971C1 (ru) | 1999-05-27 |
| CA2069594A1 (fr) | 1992-11-28 |
| TW288048B (enExample) | 1996-10-11 |
| HU215531B (hu) | 2000-05-28 |
| EP0517292B1 (fr) | 2000-02-02 |
| DK0517292T3 (da) | 2000-05-08 |
| PT517292E (pt) | 2000-06-30 |
| HU9201746D0 (en) | 1992-08-28 |
| JPH05244939A (ja) | 1993-09-24 |
| MX9202512A (es) | 1995-01-31 |
| BE1004877A3 (fr) | 1993-02-16 |
| DE69230627T2 (de) | 2000-09-28 |
| ES2145000T3 (es) | 2000-07-01 |
| IL101780A0 (en) | 1992-12-30 |
| CN1069068A (zh) | 1993-02-17 |
| BR9202024A (pt) | 1993-01-19 |
| NZ242620A (en) | 1993-09-27 |
| JP3411307B2 (ja) | 2003-05-26 |
| DE69230627D1 (de) | 2000-03-09 |
| IE921686A1 (en) | 1992-12-02 |
| KR100244601B1 (ko) | 2000-03-02 |
| CN1055501C (zh) | 2000-08-16 |
| KR920021706A (ko) | 1992-12-18 |
| SG49876A1 (en) | 2002-04-16 |
| AU1632392A (en) | 1992-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR248045A1 (es) | Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia | |
| ES2124532T3 (es) | Sistema vector-huesped utilizable en terapia genica. | |
| ES2059565T3 (es) | Virus mva de la vacuna, recombinante. | |
| FI951138A7 (fi) | Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa | |
| ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
| ES2078907T3 (es) | Metodo para radiomarcar proteinas. | |
| AR003425A1 (es) | Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv) | |
| EP0575491A4 (de) | Gentechnologisch hergestellter stamm für impfstoffe. | |
| ES2191663T3 (es) | Virus recombinante de la viruela porcina. | |
| DE68927025D1 (de) | HIV-2-Virusvarianten | |
| EP0710288A4 (en) | ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA | |
| FI971613A7 (fi) | Defektiivisiä adenoviruksia, jotka käsittävät terapeuttisen geenin ja immunoprotektiivisen geenin | |
| ATE33558T1 (de) | Stabilisierung von influenzavirusimpfstoffen. | |
| ES2120036T3 (es) | Virus recombinantes y su utilizacion en terapia genetica. | |
| FI963717A7 (fi) | Uusia mutatoituja viruksia, viruksenvastaisia yhdisteitä ja uusia menetelmiä rokotteiden valmistamiseksi | |
| MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
| ES2134197T3 (es) | Vacunas contra el virus del herpes simplex vp16. | |
| ES2127294T3 (es) | Vacunas del virus de la inmunodeficiencia anti-felino (fiv). | |
| HUP9901958A2 (hu) | Sertés reproduktív és respirációs szindróma vakcina | |
| ES2052589T3 (es) | Vector viral, codificante para una glicoproteina del virus responsable del sida, vacuna y anticuerpo. | |
| ES2196032T3 (es) | Mutantes y vacunas del virus de la anemia infecciosa de los pollos y utilizaciones basadas sobre las proteinas virales vp1, vp2 y vp3 o secuencias de dicho virus que las codifican. | |
| MX2022008547A (es) | Virus de vacuna recombinante. | |
| HUP9901035A2 (hu) | Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban | |
| ES2125236T3 (es) | Mejoras relativas a la deteccion de virus. | |
| ES2062990T3 (es) | Vacunas, que contienen la proteina f del virus del sida. |